Pandion Therapeutics competitorsClear all

Pandion Therapeutics's top competitors include ImCheck Therapeutics, Kymera Therapeutics, Rubius Therapeutics and Atara Biotherapeutics.
Pandion Therapeutics
Pandion Therapeutics
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.
ImCheck Therapeutics
ImCheck Therapeutics
ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .
Kymera Therapeutics
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
Rubius Therapeutics
Rubius Therapeutics
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
Atara Biotherapeutics
Atara Biotherapeutics
Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.
Founding Date
Founding Date
2017
Founding Date
2015
Founding Date
2017
Founding Date
2013
Founding Date
2012
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Watertown, US
Locations
Marseille, FR HQ
Locations
Watertown, US HQ
Locations
Cambridge, US HQ
Smithfield, US
Locations
South San Francisco, US HQ
Zug, CH
Aurora, US
New York, US
Thousand Oaks, US
Employees
Employees
63
Employees
403% increase
Employees
8010% increase
Employees
17423% increase
Employees
39326% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
842.7 m
Valuation ($)
1.4 b
Twitter followers
Twitter followers
250
Twitter followers
423
Twitter followers
1.8 k
Twitter followers
1.1 k
Twitter followers
1.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
19
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4.7
Average likes per tweet (last 30 days)
5
Average likes per tweet (last 30 days)
7.7
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
10.6
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
291875
Alexa Website Rank
N/A
Alexa Website Rank
336012
Alexa Website Rank
339837
Alexa Website Rank
238554

Financial

Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($167.7m) (FY, 2020)
Net income
($291m) (FY, 2019)

Funding

Latest funding round
Latest funding round
$ 80m (11 months ago)
Latest funding round
$ 53.2m (about 1 year ago)
Latest funding round
$ 102m (12 months ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 138m
Total funding raised
$ 76.1m
Total funding raised
$ 197m
Total funding raised
$ 245m
Total funding raised
$ 61.8m
For sources of this data, please see the company profile

View company profiles

ImCheck Therapeutics
HQ
Marseille, FR
Employees
40↑ 3% increase

ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .

View company
Kymera Therapeutics
HQ
Watertown, US
Employees
80↑ 10% increase

Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.

View company
Rubius Therapeutics
HQ
Cambridge, US
Employees
174↑ 23% increase

Rubius is developing a new class of drugs, Red-Cell Therapeutics™.

View company
Atara Biotherapeutics
HQ
South San Francisco, US
Employees
393↑ 26% increase

Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.

View company